Medical Devices · Healthcare
CEO
2026-09-01–present
Equibles does not estimate personal net worth.
Get an email with a short summary when Profound Medical Corp. publishes a filing, an earnings call transcript or a press release.
Get PROF alertsRichard R. Fabian is recorded as CEO at Profound Medical Corp. (PROF) since January 15, 2027. Profound Medical Corp. reported in an 8-K filed November 12, 2026 that Richard R. Fabian was appointed President and Chief Executive Officer, effective January 15, 2027. Profound Medical Corp. reported in an 8-K filed September 3, 2026 that Richard R. Fabian was appointed President, effective September 1, 2026. Richard R. Fabian has spoken on 1 earnings call and 1 other investor event across 1 company, most recently for Profound Medical Corp. on November 12, 2026. Profound Medical Corp. is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Profound Medical Corp. includes Arun Menawat (Chairman), Matthew Sobczyk (CFO), Frank Baylis (Board Member) and 1 other.
“On November 5, 2026, the Board approved a leadership transition plan pursuant to which, effective January 15, 2027 (the “Transition Date”), Richard R. Fabian, the Company’s current President, is appointed President and Chief Executive Officer of the Company, effective as of the Transition Date, and Arun Menawat will step down as Chief Executive Officer and will become Executive Chairman of the Board as of the Transition Date.”
“On September 1, 2026, Profound Medical Corp. (the "Company" or "Profound Medical") announced that Richard R. Fabian has been appointed by the Board of Directors of the Company (the "Board") to serve as the President of the Company, effective as of the same date (the "Appointment Date").”
“Thank you, Rick, and we appreciate the invitation to be at the Stiefel Conference and present our story. I won't go through it, but of course, here's our standard forward-looking statement.”
“I appreciate the confidence Arun and the board have placed in me. I look forward to leading Profound as CEO and working with Arun as Executive Chairman beginning in mid-January.”
2027-01-15–present
SEC 8-K
2026-09-01–present
Medical Devices · Healthcare
CEO
2026-09-01–present